Vertex Pharmaceuticals stock falls after pain drug fails in Phase 2 study
Synergy CHC Corp (OTC:SNYR), a $32.18 million market cap company trading at an attractive P/E ratio of 6.5x, has seen its CEO and Chairman Jack Ross actively purchasing company stock, according to a recent Form 4 filing. According to InvestingPro data, the stock has delivered a remarkable 200% return over the past year. Between June 11, 2025, and July 30, 2025, Ross acquired a total of 25,900 shares of common stock through a series of transactions. The purchases were made at prices ranging from $2.15 to $3.90, amounting to a total investment of $79,577. The stock currently trades at $3.57, with InvestingPro analysis indicating the company maintains impressive gross profit margins of 68.6%.
The series of purchases increased Ross’s direct ownership in Synergy CHC.
In addition to his direct holdings, Ross also has indirect ownership through several entities: Rosscor Brands Corp. (300,000 shares), Gowan Private Equity Inc. (3,679,056 shares), Dunhill Distribution Group, Inc. (269,635 shares) and Gowan Capital Inc. (136,559 shares).
In other recent news, Synergy CHC Corp reported a 30% increase in earnings per share for the first quarter of 2025, despite experiencing a 13% decline in net revenue compared to the previous year. This earnings growth highlights the company’s operational improvements and strategic initiatives, particularly in international markets. Additionally, Synergy CHC expanded its international licensing agreement with Gravity Pharma to include Turkey for the distribution of its FOCUSfactor brain health supplements, alongside the United Arab Emirates. This expansion resulted in $2 million in upfront licensing revenue, with potential for additional royalties based on sales performance.
In financial developments, Synergy CHC secured a $20 million term loan from ACP Agency, LLC, aimed at repaying existing debt and supporting growth initiatives. The loan includes an interest-only period until 2025, followed by structured principal repayments. Furthermore, Synergy CHC appointed Erik Shields as the new Vice President of Beverage, as the company seeks to expand its beverage offerings under the FOCUSfactor brand. Shields brings extensive experience in sales leadership within the beverage industry, which is expected to bolster Synergy’s efforts to tap into the growing market for functional beverages.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.